Category
Ruxolitinib
CAS Number
1911644-32-0
Molecular Formula
C17H20N6O
Molecular Weight
324.4 g/mol
Synonym

3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-Cyclopentylpropanamide; 1H-Pyrazole-1-propanamide, beta-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl);beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanamide

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Rac-Ruxolitinib amide is a racemic form of Ruxolitinib in which the phosphate group is replaced by an amide group. It is primarily used in medicinal chemistry research as an intermediate or analog for studying JAK (Janus kinase) inhibition and related therapeutic applications.